Healthcare -
Biotechnology - NASDAQ - US
$ 9.235
-2.69 %
$ 2.84 B
Market Cap
-51.31
P/E
FOLD - LONG-TERM DEBT
Long-term Debt FOLD - Amicus Therapeutics, Inc.
435 M
LAST VALUE
-6.25%
2 YEAR CAGR
16.47%
5 YEAR CAGR
45.11%
10 YEAR CAGR